Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice
Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice
复制标题
DOI：
10.1093/cercor/bhad502
复制
发表时间：
2024-01
期刊：
影响因子：
--
通讯作者：
Xi Zhang;Hong Zheng;Zhitao Ni;Yuying Shen;Die Wang;Wenqing Li;Liangcai Zhao;Chen Li;Hongchang Gao
中科院分区：
文献类型：
--
作者：
Xi Zhang;Hong Zheng;Zhitao Ni;Yuying Shen;Die Wang;Wenqing Li;Liangcai Zhao;Chen Li;Hongchang Gao
Abstract Diabetes mellitus (DM) causes damage to the central nervous system, resulting in cognitive impairment. Fibroblast growth factor 21 (FGF21) exhibits the potential to alleviate neurodegeneration. However, the therapeutic effect of intracerebroventricular (i.c.v) FGF21 infusion on diabetes-induced cognitive decline (DICD) and its potential mechanisms remain unclear. In this study, the impact of FGF21 on DICD was explored, and 1H nuclear magnetic resonance (NMR)-based metabolomics plus 13C NMR spectroscopy in combine with intravenous [1-13C]-glucose infusion were used to investigate the underlying metabolic mechanism. Results revealed that i.c.v FGF21 infusion effectively improved learning and memory performance of DICD mice; neuron loss and apoptosis in hippocampus and cortex were significantly blocked, suggesting a potential neuroprotective role of FGF21 in DICD. Metabolomics results revealed that FGF21 modulated DICD metabolic alterations related to glucose and neurotransmitter metabolism, which are characterized by distinct recovered enrichment of [3-13C]-lactate, [3-13C]-aspartate, [4-13C]-glutamine, [3-13C]-glutamine, [4-13C]-glutamate, and [4-13C]- γ-aminobutyric acid (GABA) from [1-13C]-glucose. Moreover, diabetes-induced neuron injury and metabolic dysfunctions might be mediated by PI3K/AKT/GSK-3β signaling pathway inactivation in the hippocampus and cortex, which were activated by i.c.v injection of FGF21. These findings indicate that i.c.v FGF21 infusion exerts its neuroprotective effect on DICD by remodeling cerebral glucose and neurotransmitter metabolism by activating the PI3K/AKT/GSK-3β signaling pathway.
